[go: up one dir, main page]

WO2000044334A3 - Novel injectable muscle relaxant formulations - Google Patents

Novel injectable muscle relaxant formulations Download PDF

Info

Publication number
WO2000044334A3
WO2000044334A3 PCT/IN2000/000005 IN0000005W WO0044334A3 WO 2000044334 A3 WO2000044334 A3 WO 2000044334A3 IN 0000005 W IN0000005 W IN 0000005W WO 0044334 A3 WO0044334 A3 WO 0044334A3
Authority
WO
WIPO (PCT)
Prior art keywords
muscle relaxant
bromide
novel injectable
formulations
injectable muscle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IN2000/000005
Other languages
French (fr)
Other versions
WO2000044334A2 (en
Inventor
Dinesh Shantilal Patel
Shshikant Prabhudas Kurani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to AU44289/00A priority Critical patent/AU4428900A/en
Publication of WO2000044334A2 publication Critical patent/WO2000044334A2/en
Anticipated expiration legal-status Critical
Publication of WO2000044334A3 publication Critical patent/WO2000044334A3/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

An adjustable mucsle relaxant formulation comprising an active material of general formula (I). Where R1 & R2= (a) in Pepecuronium Bromide; R1= (b); & R2= (c) in Vecuronium Bromide which is in solution with 2.5-di-O-methyl-1.4; 3.6-dianhydro-D-glucitol. The preferred actives are Pipecuronium Bromide and Vecuronium Bromide and analogs thereof. Conventional muscle relaxant compounds may also be added to the actives listed above.
PCT/IN2000/000005 1999-01-28 2000-01-27 Novel injectable muscle relaxant formulations Ceased WO2000044334A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU44289/00A AU4428900A (en) 1999-01-28 2000-01-27 Novel injectable muscle relaxant formulations

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN66/BOM/99 1999-01-28
IN66BO1999 1999-01-28

Publications (2)

Publication Number Publication Date
WO2000044334A2 WO2000044334A2 (en) 2000-08-03
WO2000044334A3 true WO2000044334A3 (en) 2002-04-11

Family

ID=11077280

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2000/000005 Ceased WO2000044334A2 (en) 1999-01-28 2000-01-27 Novel injectable muscle relaxant formulations

Country Status (2)

Country Link
AU (1) AU4428900A (en)
WO (1) WO2000044334A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7838515B2 (en) 2005-04-15 2010-11-23 Lyotropic Therapeutics, Inc. Formulations of quaternary ammonium neuromuscular blocking agents
CN102558276B (en) * 2011-12-23 2013-10-30 成都科瑞德医药投资有限责任公司 Non-sizing pipecuronium and preparation method and purpose thereof
EP2712611A1 (en) 2012-09-27 2014-04-02 B. Braun Melsungen AG Stabilized aqueous compositions of neuromuscular blocking agents
CN108938573B (en) * 2017-05-26 2021-08-10 四川科瑞德制药股份有限公司 Neuromuscular blocker composition and preparation method and application thereof
CN109125259A (en) * 2018-10-25 2019-01-04 上药东英（江苏）药业有限公司 A kind of preparation method of the benzene sulphur without preservative along atracurium injection

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994017808A1 (en) * 1993-02-08 1994-08-18 N.V. Inpharm Process to prepare pharmaceutical compositions containing vecuronium bromide
WO1995029677A1 (en) * 1994-04-28 1995-11-09 Bionumerik Pharmaceuticals, Inc. Lactone stable formulation of camptothecin or 7-ethyl camptothecin
US5767112A (en) * 1994-10-21 1998-06-16 Poli Industria Chimica, S.P.A. Muscle relaxant pharmaceutical compositions

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994017808A1 (en) * 1993-02-08 1994-08-18 N.V. Inpharm Process to prepare pharmaceutical compositions containing vecuronium bromide
WO1995029677A1 (en) * 1994-04-28 1995-11-09 Bionumerik Pharmaceuticals, Inc. Lactone stable formulation of camptothecin or 7-ethyl camptothecin
US5767112A (en) * 1994-10-21 1998-06-16 Poli Industria Chimica, S.P.A. Muscle relaxant pharmaceutical compositions

Also Published As

Publication number Publication date
AU4428900A (en) 2000-08-18
WO2000044334A2 (en) 2000-08-03

Similar Documents

Publication Publication Date Title
MX9801111A (en) Chewable molded tablet containing medicinally active substances.
CA2239174A1 (en) Novel compounds with analgesic effect
EA200100838A1 (en) GKSF CONJUGATES
HUP9802822A3 (en) Halobenzimidazol derivatives, intermediates, preparation thereof and microbocide compositions containing these compounds as active ingredients
MY101843A (en) Block polyesters and like compounds useful as soil release agents in detergent compositions.
HRP20010779B1 (en) PHARMACEUTICAL PREPARATION
IL109526A0 (en) Benzofuranyl- and thiophenyl-alkanecarboxylic acid derivatives, their preparation and pharmaceutical compositions containing them
IE812075L (en) Composition
CA2295599A1 (en) Novel heterocyclic analogs of diphenylethylene compounds
EP1166766A4 (en) External preparation compositions
AU626749B2 (en) Transparent cosmetic composition containing glycerol, soap, and soap crystal growth inhibitor
FR2601259B1 (en) NOVEL SURFACTANT COMPOSITIONS BASED ON PHOSPHORIC ESTERS, THEIR PREPARATION PROCESS AND THEIR APPLICATION TO THE FORMULATION OF ACTIVE MATERIALS.
RU94046044A (en) NEW 7β-SUBSTITUTED 4-AZA-5a-CHOLESTAN-ONES AS INHIBITORS OF 5a-REDUCTASE, PHARMACEUTICAL COMPOSITION BASED ON THEREOF, METHOD OF ITS PREPARING
SG46307A1 (en) New pyrazine derivatives the preparation and use thereof
PT615754E (en) SOLID FORMS OF CONTROLLED LIBERATION ORAL ADMINISTRATION FLUPERTINE
CA2360300A1 (en) A transdermal composition of an antivomiting agent and a preparation containing the same
ATE38991T1 (en) 2-POSITION-SUBSTITUTED 1,3PROPYLEDENDEPHOSPHONATE DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
CA2285242A1 (en) Mixture of primary fatty acids obtained from sugar cane wax
IE781032L (en) Pharmaceutical compositions
WO2000044334A3 (en) Novel injectable muscle relaxant formulations
JPS56161323A (en) Anti-inflammatory and pain-killing gel
CA2048408A1 (en) Acyl isethionate skin cleansing compositions containing selected betaines
AU1403788A (en) Substituted 2-mercapto-5-pyrazinyl-1,3,4-oxadiazoles and 2-mercapto-5-pyrazinyl-1,3,4-thiadiazoles, to their preparation and to nematicidal compositions which contain at least one of these compounds as active ingredient
WO2002011668A3 (en) 5'-deoxy-n-(substituted oxycarbonyl)-5-fluorocytosine and derivatives thereof, method of preparing same, and anticancer composition comprising same as active ingredients
TR199900013T2 (en) New bracelets.

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

122 Ep: pct application non-entry in european phase